US Broker Ratings

CONMED Corporation (CNMD) Stock Analysis: Navigating a 26.7% Potential Upside in the Medical Devices Sector

As individual investors eye opportunities within the healthcare sector, CONMED Corporation (NASDAQ: CNMD) stands out with a compelling 26.7% potential upside. This medical technology company, headquartered in Largo, Florida, specializes..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 139% Potential Upside in Biotech

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company, is gaining attention within the healthcare sector due to its regenerative medicine products and significant growth potential. With a market capitalization of..

Ultragenyx Pharmaceutical Inc. (RARE): Analyst Consensus Reveals 148% Potential Upside Amidst Robust Revenue Growth

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the healthcare sector as a pioneering biopharmaceutical company focused on the development of novel treatments for rare and ultra-rare genetic diseases. With..

Arrowhead Pharmaceuticals (ARWR): Investor Outlook Reveals Promising 41.82% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has captured the attention of investors with its impressive growth trajectory and a robust pipeline of innovative therapeutic solutions. As a prominent player in the..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 33% Potential Upside

Investors eyeing opportunities in the healthcare sector might want to take a closer look at U.S. Physical Therapy, Inc. (NYSE: USPH), a company that stands out with a notable 33.37%..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating Its 20.69% Potential Upside Amid Innovative Growth

10x Genomics, Inc. (NASDAQ: TXG) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.13 billion, this Pleasanton,..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Biotechnology Innovator with 34.88% Potential Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) stands at an intriguing juncture for investors, especially given its position in the rapidly evolving biotechnology sector. With a market capitalization of $3.19 billion, this..

Galapagos NV (GLPG) Stock Analysis: Evaluating Growth Potential Amidst Biotech Volatility

For investors navigating the ever-evolving landscape of biotechnology stocks, Galapagos NV (NASDAQ: GLPG) presents a unique case study. Headquartered in Mechelen, Belgium, Galapagos operates within the healthcare sector, focusing on..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Contender with 60.79% Upside Potential

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biotechnology firm, has emerged as a notable name in the healthcare sector, particularly with its focus on cardiometabolic diseases. With a market..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Healthcare Player with a 16.91% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) is making waves in the healthcare sector, particularly in the niche market of long-term care facilities (LTCFs) across the United States. As a provider..

SS Innovations International (SSII) Performance Highlights: Exploring 79.10% Revenue Growth and Strategic Positioning in Medical Devices

SS Innovations International, Inc. (SSII), a trailblazer in the medical devices sector, is making waves in the healthcare industry with its cutting-edge surgical robotics. Headquartered in Gurugram, India, the company..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Is a 110% Upside Within Reach?

Dyne Therapeutics, Inc. (NASDAQ: DYN) is currently capturing the attention of investors, with a potential upside of 110.63% according to analyst ratings. This clinical-stage biotechnology company, based in Waltham, Massachusetts,..

Protagonist Therapeutics (PTGX) Stock Analysis: Exploring a Promising 11.46% Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) has been capturing investor attention with its strategic focus on innovative therapies within the biotechnology sector. The company, headquartered in Newark, California, is making waves..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals Strong Potential Upside of 43.88%

ICU Medical, Inc. (NASDAQ: ICUI) stands as a pivotal player in the healthcare sector, specializing in the development and sale of medical instruments and supplies. With a market capitalization of..

BGM Group Ltd. (BGM) Stock Analysis: Revenue Plunge and Strategic Shifts in Focus for Investors

BGM Group Ltd. (BGM), a player in the healthcare sector with a focus on the specialty and generic drug manufacturing industry, is navigating challenging market conditions. Based in Chengdu, China,..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring Robust Revenue Growth and a Solid Market Position

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, has been capturing the attention of investors with its robust..

Recursion Pharmaceuticals (RXRX) Stock Analysis: Navigating a 98% Potential Upside in the Biotech Arena

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is garnering significant attention in the biotechnology sector, particularly due to its impressive 98.06% potential upside as indicated by analyst target price ranges. As a..

Vericel Corporation (VCEL) Stock Analysis: A 71.66% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 71.66%, according to analyst consensus. Headquartered in Cambridge, Massachusetts, Vericel..

Adaptive Biotechnologies Corpor (ADPT) Stock Analysis: A 56% Upside Potential Amid Strong Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering entity in the biotechnology sector, is capturing the attention of investors with its promising 56.59% potential upside. As a commercial-stage company headquartered in..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 50% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player within the healthcare sector, specifically in the medical instruments and supplies industry. Based in Kirkland, Washington, the company specializes..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds